229 related articles for article (PubMed ID: 30952616)
1. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
Schittenhelm MM; Walter B; Tsintari V; Federmann B; Bajrami Saipi M; Akmut F; Illing B; Mau-Holzmann U; Fend F; Lopez CD; Kampa-Schittenhelm KM
EBioMedicine; 2019 Apr; 42():340-351. PubMed ID: 30952616
[TBL] [Abstract][Full Text] [Related]
2. ASPP2κ Is Expressed In Human Colorectal Carcinoma And Promotes Chemotherapy Resistance And Tumorigenesis.
Rieger I; Tsintari V; Overkamp M; Fend F; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
Front Mol Biosci; 2021; 8():727203. PubMed ID: 34805267
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of Apoptosis Stimulating Protein of TP53-2 (ASPP2) results in an oncogenic isoform promoting migration and therapy resistance in soft tissue sarcoma (STS).
Tsintari V; Walter B; Fend F; Overkamp M; Rothermundt C; Lopez CD; Schittenhelm MM; Kampa-Schittenhelm KM
BMC Cancer; 2022 Jul; 22(1):725. PubMed ID: 35780096
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia.
Kampa-Schittenhelm KM; Haverkamp T; Bonin M; Tsintari V; Bühring HJ; Haeusser L; Blumenstock G; Dreher ST; Ganief T; Akmut F; Illing B; Mau-Holzmann UA; Bonzheim I; Schleicher E; Vogel W; Schittenhelm MM
EBioMedicine; 2020 Apr; 54():102678. PubMed ID: 32272438
[TBL] [Abstract][Full Text] [Related]
5. Attenuated expression of apoptosis stimulating protein of p53-2 (ASPP2) in human acute leukemia is associated with therapy failure.
Schittenhelm MM; Illing B; Ahmut F; Rasp KH; Blumenstock G; Döhner K; Lopez CD; Kampa-Schittenhelm KM
PLoS One; 2013; 8(11):e80193. PubMed ID: 24312201
[TBL] [Abstract][Full Text] [Related]
6. ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival.
Van Hook K; Wang Z; Chen D; Nold C; Zhu Z; Anur P; Lee HJ; Yu Z; Sheppard B; Dai MS; Sears R; Spellman P; Lopez CD
Biochem Biophys Res Commun; 2017 Jan; 482(4):1271-1277. PubMed ID: 27939881
[TBL] [Abstract][Full Text] [Related]
7. Alternative messenger RNA splicing of autophagic gene Beclin 1 in human B-cell acute lymphoblastic leukemia cells.
Niu YN; Liu QQ; Zhang SP; Yuan N; Cao Y; Cai JY; Lin WW; Xu F; Wang ZJ; Chen B; Wang JR
Asian Pac J Cancer Prev; 2014; 15(5):2153-8. PubMed ID: 24716949
[TBL] [Abstract][Full Text] [Related]
8. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E
Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806
[TBL] [Abstract][Full Text] [Related]
10. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
[TBL] [Abstract][Full Text] [Related]
11. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
12. TP53 codon 72 polymorphism and risk of acute leukemia.
Dunna NR; Vure S; Sailaja K; Surekha D; Raghunadharao D; Rajappa S; Vishnupriya S
Asian Pac J Cancer Prev; 2012; 13(1):347-50. PubMed ID: 22502699
[TBL] [Abstract][Full Text] [Related]
13. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
[TBL] [Abstract][Full Text] [Related]
14. Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathway.
Eisfeld AK; Schwind S; Patel R; Huang X; Santhanam R; Walker CJ; Markowitz J; Hoag KW; Jarvinen TM; Leffel B; Perrotti D; Carson WE; Marcucci G; Bloomfield CD; de la Chapelle A
Sci Signal; 2014 Apr; 7(321):ra36. PubMed ID: 24736457
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
Oh L; Hainaut P; Blanchet S; Ariffin H
BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
[TBL] [Abstract][Full Text] [Related]
16. [Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
Kitamura K; Matsushita K; Kobayashi S; Ishige T; Semba T; Kimura A; Kazami T; Ohyama M; Itoga S; Beppu M; Nishimura M; Satoh M; Nomura F
Rinsho Byori; 2015 Sep; 63(9):1091-102. PubMed ID: 26731899
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
[TBL] [Abstract][Full Text] [Related]
18. TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells.
Lynch JT; Somerville TD; Spencer GJ; Huang X; Somervaille TC
Cell Death Dis; 2013 Apr; 4(4):e573. PubMed ID: 23559008
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
[TBL] [Abstract][Full Text] [Related]
20. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
